Adam Szulkin

Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma

Oluf Dimitri Røe, Adam Szulkin, Endre Anderssen et al. · PLoS ONE · 2012 · 37 citations · Full text

Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

Adam Szulkin, Rita Ötvös, Carl-Olof Hillerdal et al. · BMC Cancer · 2014 · 35 citations · Full text

Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure

Gustav Nilsonne, Eric Olm, Adam Szulkin et al. · Journal of Experimental & Clinical Cancer Research · 2009 · 23 citations · Full text

Variation in Drug Sensitivity of Malignant Mesothelioma Cell Lines with Substantial Effects of Selenite and Bortezomib, Highlights Need for Individualized Therapy

Adam Szulkin, Gustav Nilsonne, Filip Mundt et al. · PLoS ONE · 2013 · 18 citations · Full text

Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma

Rita Ötvös, Adam Szulkin, Carl-Olof Hiilerdal et al. · Genes & Cancer · 2015 · 11 citations · Full text